Cellectricon Receives Swedish Governmental R&D; Grant

Date Posted: Friday, September 22, 2006

Print Email to a friend

Cellectricon has received a grant totaling SEK 2.3 million from VINNOVA (The Swedish Governmental Agency for Innovation Systems).

The VINNOVA grant was awarded for the development of Cellectricon's next generation microfluidics platform for high-resolution GPCR screening.

"The VINNOVA grant validates the potential of Cellectricon's unique miniaturized cell-based screening systems for drug discovery", says Dr. Mattias Karlsson, Chief Operating Officer at Cellectricon.

"The market acceptance of our launched products together with the VINNOVA grant is gratifying and we will continue to focus on providing innovative solutions for our customers."

Further Information: http://www.cellectricon.com/index2.html

Related Products

Cellectricon Launches Dynaflow™ Pro II System
The system comes with the DF-8 Pro II Chip beta-tested for conducting GLP hERG studies.

Related news from our archive

Cellectricon Signs Collaboration Agreement with AstraZeneca
The collaboration aims to advance the performance of cell-based ion channel assays in screening applications.